Territorial licensing: "start at the end before you begin"
von Colin McCall und Justyna Ostrowska
Impact of COVID-19 on venture-backed biotech companies – Part 2: Investment and cash flow
von Adrian Toutoungi und Josef Fuss
Impact of COVID-19 on venture-backed biotech companies – Part 1: Operational issues
von Adrian Toutoungi und Josef Fuss
A missed chance
von Dr. Anja Lunze, LL.M. und Verena Bertram
NHS can procure drugs for use outside of their approved indications if it's cheaper, court says
Everything biologic and biosimilar in-house counsel need to know about COVID-19
von mehreren Autoren
Patent pools: an easy licensing option for COVID-19 drugs and SARS CoV 2 vaccines?
An exploration of patent pools, R&D and current initiatives.
von Dr. Anja Lunze, LL.M. und Dr. Jan Phillip Rektorschek
2 von 6 Insights
Termination, force majeure and frustration – international perspectives on the life sciences sector
von mehreren Autoren
COVID-19 and life sciences M&A
von mehreren Autoren
Zulassung und klinische Prüfung neuer Medikamente
Competition law issues shaping the pharmaceutical sector
von Paolo Palmigiano und Louisa Penny